Pharmaceutical Juris MCQ for loksewa and NPC exam [part 2]

 Pharmaceutical Juris MCQ for loksewa and NPC exam 

[part 2]

 1. Section 17 of Drug act 2035 

 a. Categorization of drug. 

b. Price fix. 

c. speaks about Clinical trial 

d. Advertisement 

2. When was APPON established? 

 a. 1972 

b. 1990 

c. 1986 

d. 1997 

3. Minimum qualification of chairman of Nepal pharmacy council. 

 a. 10 year experience only 

 b. Master degree only 

 c. B.pharm with 10 year experience in the pharmacy profession. 

 d. PhD 

4. DDA was established in 

 a. 2036 

b. 2048 

c. 2035 

d. 2057 

5. NNF was published in 

 a. 1990 

b. 1997 

c. 2035 

d. 1972 

6. Nepal pharmacy council was established in 

 a. 2057 

c. 2035 

b. 2058 

d. all 

7. Which section of national drug policy provides prudent use of antibiotics? 

 a. 4.1.1 

b. 4.3.2 

c. 4.3.3 

d. all 

8. How many pharmacopoeia are recognized in Nepal 

 a. 9 

b. 10 

c. 11 

d. 12 

9. Provisions of recommended letter to be obtained to established drug industry is mentioned in 

 a. Chapter 4 

b. Section 7 

c. Both 

d. None 

10. Which of the following combination of drug is notbanned in Nepal? 

 a. Codilne + Caffeine 

b. Metronidazole+ Ciprofloxacillin 

 c. Oxacillin Clavulanic acid 

d. Vitamin +Mineral+ Enzyme 

11. Cold temperature means: 

 a. 2-8 degree 

b. 8-15 degree 

c. 15-25 degree 

d. above 25 degree 

12. The renewal period of license, recommendation letter and certificate after validity period is 

 a. 35 days 

b. 1 month 

c. 36 days 

d. 1 Year 

13. The validity period of the certificate after issuance is 

 a. l year 

b. 2 year 

c. 3year 

d. 4 year 

14. First private pharmaceutical company of Nepal is ? 

 a. NPL 

b. Curex 

c. DJPL 

d. Chemi drug 

15. Which university first established pharmacy programme in Nepal? 

 a. KU 

b. Pokhara University 

 c. TU 

d. Purbanchal university 

16. Which of the following pharmacopoeia is not official in 

 a. IP 

b. USP 

 d. Chinese pharmacopoeia 

d. None 

17. The second revision of drug act in [B.S.] 

 a. 2035 

b. 2057 

c. 2045 

d. 2072 

18. Which section of drug sales and distribution code 2071 provide the provision of 

pharmacovigilance 

 a. section 8 

b. section 9 

c. section 11 

d. Section 10 

19. Drug registration regulation was revised in[B.S.] 

 a. 2058 

b. 2068 

c. 2038 

d. 2057 

20. Drug standard regulation was published in update of Nepal 

 a. 2041 

b. 2041 

c. 2043 

d. 2038 

Available at Heritage Publication

For Answer click on image: